Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Triazole-fused pyrimidines in target-based anticancer drug discovery
Xing‐Jie Dai, Lei-Peng Xue, Shi‐Kun Ji, et al.
European Journal of Medicinal Chemistry (2023) Vol. 249, pp. 115101-115101
Closed Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Multicomponent reactions (MCRs) yielding medicinally relevant rings: a recent update and chemical space analysis of the scaffolds
Mukesh Tandi, Vaibhav Sharma, B. Gopal, et al.
RSC Advances (2025) Vol. 15, Iss. 2, pp. 1447-1489
Open Access | Times Cited: 1
Novel 1,2,4-triazole-maleamic acid derivatives: synthesis and evaluation as anticancer agents with carbonic anhydrase inhibitory activity
Michael Tapera, Hüseyin Kekeçmuhammed, Burak Tüzün, et al.
Journal of Molecular Structure (2024) Vol. 1313, pp. 138680-138680
Closed Access | Times Cited: 8
A Review of Click Chemistry in the Synthesis of Organophosphorus Triazoles and Their Biological Activities
Mariam T. Sayed, Mohamed F. Mady
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117270-117270
Open Access
Design, synthesis, and antitumor activity evaluation of BF3-o, m, p-phenylenediamine bridged with pyrimidine-indole BF3 adduction derivatives
Meng Zhou, Xiujie Duan, Tao Jin, et al.
Molecular Diversity (2024) Vol. 29, Iss. 1, pp. 425-437
Closed Access | Times Cited: 3
Synthesis of Novel Triazine-Based Chalcones and 8,9-dihydro-7H-pyrimido[4,5-b][1,4]diazepines as Potential Leads in the Search of Anticancer, Antibacterial and Antifungal Agents
Leydi M. Moreno, Jairo Quiroga, Rodrigo Abonı́a, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3623-3623
Open Access | Times Cited: 2
Ring-Opening Coupling of Cyclopropanol with 1,2,3-Triazole for the Synthesis of Fused Triazoles
Yi Wu, Hu Zhang, Qi Wang, et al.
Organic Letters (2024) Vol. 26, Iss. 19, pp. 4043-4048
Closed Access | Times Cited: 2
Photoinduced Ordered Growth of Copper-Doped Polyaniline Nanotubes: A Method to Improve the Catalytic Activity for C–N Coupling Reactions
Ying Chen, Yiyang Zhang, Hongwei Zhou, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 29, pp. 37906-37914
Closed Access | Times Cited: 2
Small molecules targeting HDAC6 for cancer treatment: Current progress and novel strategies
Ziqian Huang, Ling Li, Binbin Cheng, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117218-117218
Open Access | Times Cited: 2
Design, synthesis and molecular docking study of novel quinoline–triazole molecular hybrids as anticancer agents
Rajubai D. Bakale, Amruta N. Bhagat, Udhav V. Mhetre, et al.
Journal of Molecular Structure (2024), pp. 140072-140072
Closed Access | Times Cited: 2
New Indazol-Pyrimidine-Based Derivatives as Selective Anticancer Agents: Design, Synthesis, and In Silico Studies
Hanaa M. Al-Tuwaijri, Ebtehal S. Al‐Abdullah, Ahmed A. El‐Rashedy, et al.
Molecules (2023) Vol. 28, Iss. 9, pp. 3664-3664
Open Access | Times Cited: 7
Regioselective Access to 1,2,4-Triazole-Fused N-Heterocycle, Pyrrolo[1,2-a][1,2,4]triazolo[5,1-c]pyrazine, via Double Dehydrative Cyclizations
Hyunjin Oh, Hye‐Yeon Kim, Ikyon Kim
The Journal of Organic Chemistry (2023) Vol. 88, Iss. 16, pp. 11748-11761
Closed Access | Times Cited: 7
Design, synthesis, biological evaluation and molecular docking study of new pyrazolo[1,5-a]pyrimidines as PIM kinase inhibitors and apoptosis inducers
Fatma G. Abdulrahman, Rehab Sabour, Shimaa M. Abd El‐Gilil, et al.
Journal of Molecular Structure (2023) Vol. 1295, pp. 136811-136811
Closed Access | Times Cited: 7
Recent drug design strategies and identification of key heterocyclic scaffolds for promising anticancer targets
Alia Mushtaq, Peng Wu, Muhammad Moazzam Naseer
Pharmacology & Therapeutics (2023) Vol. 254, pp. 108579-108579
Closed Access | Times Cited: 7
New NADPH Oxidase 2 Inhibitors Display Potent Activity against Oxidative Stress by Targeting p22phox-p47phox Interactions
Adriana V. Treuer, Mario Faúndez, Roberto Ebensperger, et al.
Antioxidants (2023) Vol. 12, Iss. 7, pp. 1441-1441
Open Access | Times Cited: 5
New library of pyrimido[5,4-e][1,2,4]triazolo[1,5-c]pyrimidine derivatives: Synthesis, herbicidal activity, and molecular docking study
Jin Luo, Huixiang Nie, Linghui He, et al.
Journal of Molecular Structure (2023) Vol. 1300, pp. 137246-137246
Closed Access | Times Cited: 5
Exploring the interaction of biologically active compounds with DNA through the application of the SwitchSense technique, UV–Vis spectroscopy, and computational methods
Aleksandra Ciesielska, Jakub Brzeski, Dorota Zarzeczańska, et al.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2024) Vol. 316, pp. 124313-124313
Open Access | Times Cited: 1
Synthesis of Fused Pyrimidines from Azole Amines and Their Biological Activity
Yumeng Zhuang, Xianzhang Wang, Bowen Liu, et al.
European Journal of Organic Chemistry (2024) Vol. 27, Iss. 43
Closed Access | Times Cited: 1
Design, synthesis, and biological investigation of selective human carbonic anhydrase II, IX, and XII inhibitors using 7-aryl/heteroaryl triazolopyrimidines bearing a sulfanilamide scaffold
Romeo Romagnoli, Tiziano De Ventura, Stefano Manfredini, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 4
In-silico and in-vitro identification of triazole based compounds as potential EGFR inhibitors targeting lung cancer
Sunil Kumar, Monu Kumar Shukla, Iqra Ali, et al.
Molecular Simulation (2023) Vol. 49, Iss. 17, pp. 1614-1631
Closed Access | Times Cited: 3
Novel hybrid motifs of 2-(2-pyridinyl)-1H-benzo[d]imidazole-1,2,3-triazole: Synthesis, anticancer assessment, and in silico study
Salhah D. Al‐Qahtani, Ghadah M. Al‐Senani
Journal of Molecular Structure (2024) Vol. 1318, pp. 139376-139376
Closed Access
Synthesis of Bi- and Polycyclic Pyrimidine Derivatives
Tat'yana V. Sokolnikova, A. G. Proidakov, М. В. Пензик, et al.
Russian Journal of Organic Chemistry (2024) Vol. 60, Iss. 6, pp. 1006-1012
Closed Access
Design, Synthesis, and Evaluation of Quinoline‐1,2,3‐Triazole Hybrids as CYP51 Inhibitors: In Silico Study and In Vitro Antimicrobial Assessment
Bhadreshkumar K. Chabhadiya, Hem N. Naik, Bhavika A. Mohite, et al.
ChemistrySelect (2024) Vol. 9, Iss. 36
Closed Access
Design, synthesis, and in vitro and in vivo biological evaluation of triazolopyrimidine hybrids as multitarget directed anticancer agents
Heba Adawy, Samar S. Tawfik, Abdullah A. Elgazar, et al.
RSC Advances (2024) Vol. 14, Iss. 48, pp. 35239-35254
Open Access
Six-membered ring systems: Diazines and benzo derivatives
K. Alison Rinderspacher
Progress in heterocyclic chemistry (2024), pp. 355-393
Closed Access
A Greener Process for the Synthesis of Base‐Catalyzed Substituted Pyrazoles and Triazolopyrimidines as Prospective Biological Activity
Wafa A. Bawazir, Zahra M. Al-Amshany, Reda M. El‐Shishtawy, et al.
ChemistrySelect (2024) Vol. 9, Iss. 48
Closed Access
Page 1 - Next Page

Scroll to top